Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Br J Dermatol. 2022 Jun 2;187(2):223–233. doi: 10.1111/bjd.21060

Figure 6: Correlation of biomarkers with molecular disease activity at week 12.

Figure 6:

A) Expression of baseline LCN2 expression in lesional skin correlated with changes in inflammatory markers at week 12 in perilesional skin. B) expression of IL-17A in serum correlate with a decrease of inflammatory markers at week (W) 12 in perilesional skin. r is Spearman correlation. X axis is log2(Expression).